Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Genes & Diseases|September 28, 2018
<i>ESR1</i> mutations: Pièce de résistanceBerry Button, Ben Ho ParkClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
BEAMing sheds light on drug resistanceJosh Lauring, Ben Ho ParkClinical Advances in Hematology & Oncology : H&O|March 19, 2021
Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applicationsSarah Croessmann, Ben Ho ParkJournal of Mammary Gland Biology and Neoplasia|August 7, 2012
Targeting the PI3K/Akt/mTOR pathway for breast cancer therapyJustin Cidado, Ben Ho ParkAnnual Review of Medicine|August 29, 2017
Circulating Tumor DNA: Measurement and Clinical UtilityJoshua Donaldson, Ben Ho ParkVirchows Archiv : an International Journal of Pathology|May 4, 2017
Liquid biopsy: unlocking the potentials of cell-free DNADavid Chu, Ben Ho ParkThe Journal of Clinical Investigation|July 29, 2010
PIK3CA and KRAS mutations predict for response to everolimus therapy: now that's RAD001Morassa Mohseni, Ben Ho ParkBiochimica Et Biophysica Acta|March 26, 2016
Use of cell free DNA in breast oncologyJenna VanLiere Canzoniero, Ben Ho ParkCancer Cell|October 16, 2007
PI3 kinase activation and response to Trastuzumab Therapy: what's neu with herceptin resistance?Ben Ho Park, Nancy E DavidsonAnnals of Translational Medicine|October 22, 2014
Plasma tumor DNA: on your markers, get set, go!Hong Yuen Wong, Ben Ho ParkPageof 12